BRD9 and B-cell chronic lymphocytic leukemia: In our BRD9 inhibition experiments, the SF3B1MUT CLL and AML cell lines, CII and HNT34, respectively, were sensitive to I-BRD9, both regarding increased apoptosis and decreased proliferation rate.